Raman-Tangella Vidya 4
4 · Teladoc Health, Inc. · Filed Sep 4, 2024
Insider Transaction Report
Form 4
Raman-Tangella Vidya
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2024-08-30+792→ 32,922 total - Sale
Common Stock
2024-09-03$7.16/sh−1,114$7,981→ 34,133 total - Exercise/Conversion
Performance Stock Units
2024-08-30−792→ 4,756 total→ Common Stock (792 underlying) - Exercise/Conversion
Common Stock
2024-08-30+2,325→ 35,247 total - Exercise/Conversion
Restricted Stock Units
2024-08-30−2,325→ 13,952 total→ Common Stock (2,325 underlying)
Footnotes (5)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 3, 2023, the reporting person was granted 27,902 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.